United States
Germany
Japan
United Kingdom
China
FGF21 mouse monoclonal antibody, clone OTI2F10 (formerly 2F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
Anti-CDX2 mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)
| Applications | IF, WB |
| Reactivities | Human, Dog, Mouse, Rat |
热销推荐
CD44 mouse monoclonal antibody, clone OTI1G1 (formerly 1G1)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD34 mouse monoclonal antibody, clone OTI51A1 (formerly 51A1)
| Applications | FC, IF |
| Reactivities | Human |
TAL1 mouse monoclonal antibody, clone OTI4G10 (formerly 4G10)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
FGF21 mouse monoclonal antibody, clone OTI2F10 (formerly 2F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
CD4 mouse monoclonal antibody, clone OTI4A11 (formerly 4A11)
| Applications | IF, WB |
| Reactivities | Human |
HDAC1 mouse monoclonal antibody, clone OTI2E9 (formerly 2E9)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
Anti-CDX2 mouse monoclonal antibody, clone OTI3G4 (formerly 3G4)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Anti-CDX2 mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)
| Applications | IF, WB |
| Reactivities | Human, Dog, Mouse, Rat |
CD44 mouse monoclonal antibody, clone OTI1G1 (formerly 1G1)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD34 mouse monoclonal antibody, clone OTI51A1 (formerly 51A1)
| Applications | FC, IF |
| Reactivities | Human |
HDAC1 mouse monoclonal antibody, clone OTI2E9 (formerly 2E9)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
TAL1 mouse monoclonal antibody, clone OTI4G10 (formerly 4G10)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Knockout (KO) Validation
Clonalities
Brands
Pathways
- Hematopoietic cell lineage (7)
- Cell adhesion molecules (CAMs) (5)
- Pathways in cancer (4)
- Antigen processing and presentation (3)
- Primary immunodeficiency (3)
- T cell receptor signaling pathway (3)
- Cell cycle (2)
- Chronic myeloid leukemia (2)
- ECM-receptor interaction (2)
- Huntington's disease (2)
- MAPK signaling pathway (2)
- Melanoma (2)
- Notch signaling pathway (2)
- Regulation of actin cytoskeleton (2)
